These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 15780526

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S, Mercuri A, Zucchelli GC, Vassalle C.
    Int J Cardiol; 2006 Feb 15; 107(2):194-9. PubMed ID: 16412796
    [Abstract] [Full Text] [Related]

  • 23. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K, Rogatko I, Milewicz T, Józef K, Tomasik PJ, Szafran Z.
    Menopause; 2005 Feb 15; 12(5):630-638. PubMed ID: 16145319
    [Abstract] [Full Text] [Related]

  • 24. Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients.
    Sachet JC, Borba EF, Bonfá E, Vinagre CG, Silva VM, Maranhão RC.
    Lupus; 2007 Feb 15; 16(4):273-8. PubMed ID: 17439934
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC, Cosper P, Nakhuda GS, Lobo RA.
    Fertil Steril; 2006 Dec 15; 86(6):1669-75. PubMed ID: 17074346
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb 15; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Transdermal progesterone cream as an alternative progestin in hormone therapy.
    Leonetti HB, Landes J, Steinberg D, Anasti JN.
    Altern Ther Health Med; 2005 Feb 15; 11(6):36-8. PubMed ID: 16320858
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Transdermal estradiol reduces plasma myeloperoxidase levels without affecting the LDL resistance to oxidation or the LDL particle size.
    Hermenegildo C, García-Martínez MC, Valldecabres C, Tarín JJ, Cano A.
    Menopause; 2002 Feb 15; 9(2):102-9. PubMed ID: 11875328
    [Abstract] [Full Text] [Related]

  • 38. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 15; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 39. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 40. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH.
    Arterioscler Thromb Vasc Biol; 2005 Aug 20; 25(8):1691-6. PubMed ID: 15933247
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.